{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:27:06Z","timestamp":1773282426255,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T00:00:00Z","timestamp":1138320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/sj.eye.6702232","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T12:50:45Z","timestamp":1138366245000},"page":"480-486","source":"Crossref","is-referenced-by-count":19,"title":["National survey of the technique of intravitreal triamcinolone injection in the United Kingdom"],"prefix":"10.1038","volume":"21","author":[{"given":"D R","family":"Anijeet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bhagey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,27]]},"reference":[{"key":"BF6702232_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","volume":"132","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Sofker A . Intraocular injection of crystalline cortisone as an adjunctive treatment of diabetic macular oedema. Am J Ophthalmol 2001; 132: 425\u2013427.","journal-title":"Am J Ophthalmol"},{"issue":"Supplement","key":"BF6702232_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00006982-200410001-00002","volume":"24","author":"LLOYD P. AIELLO","year":"2004","unstructured":"Aiello PL, Brucker JA, Chang S, Cunningham Jr ET, D' Amico DJ, Flynn Jr HW et al. Evolving guidelines for intravitreous injections. Retina 2004; S3\u2013S19.","journal-title":"Retina"},{"key":"BF6702232_CR3","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","volume":"84","author":"JB Jonas","year":"2000","unstructured":"Jonas JB, Hayler JK, Panda- Jonas S . Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000; 84: 1064\u20131067.","journal-title":"Br J Ophthalmol"},{"key":"BF6702232_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","volume":"131","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Hayler JK, Sofker A, Panda-Jonas S . Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131: 468\u2013471.","journal-title":"Am J Ophthalmol"},{"key":"BF6702232_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s004170100293","volume":"239","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Hayler JK, Panda- Jonas S . Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony. Graef Arch Clin Exp Ophthalmol 2001; 239: 464\u2013465.","journal-title":"Graef Arch Clin Exp Ophthalmol"},{"key":"BF6702232_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/bjo.86.2.247","volume":"86","author":"PB Greenberg","year":"2002","unstructured":"Greenberg PB, Marthidis A, Rogers AH, Duker JS, Reichel E . Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86: 247\u2013248.","journal-title":"Br J Ophthalmol"},{"key":"BF6702232_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","volume":"108","author":"RJ Antcliff","year":"2001","unstructured":"Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J . Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study. Ophthalmology 2001; 108: 765\u2013772.","journal-title":"Ophthalmology"},{"key":"BF6702232_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","volume":"20","author":"RP Danis","year":"2000","unstructured":"Danis RP, Thomas A, Ciulla TA, Pratt LM, Anilekar W . Intravitreal triamcinolone acetonide in exudative age related macular degeneration. Retina 2000; 20: 244\u2013250.","journal-title":"Retina"},{"key":"BF6702232_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 2002; 109: 920\u2013927.","journal-title":"Ophthalmology"},{"issue":"1","key":"BF6702232_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archopht.121.1.57","volume":"121","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Sofker A, Degenring RF . Intravitreal injection of triamcinolone for diffuse diabetic macular oedema. Arch Ophthalmol 2003; 121 (1): 57\u201361.","journal-title":"Arch Ophthalmol"},{"key":"BF6702232_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","volume":"101","author":"T Hida","year":"1986","unstructured":"Hida T, Chandler D, Arena JE, Marchemer R . Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986; 101: 190\u2013195.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"BF6702232_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s10384-003-0053-8","volume":"48","author":"CK Yeung","year":"2004","unstructured":"Yeung CK, Chan KP, Chan CK, Pang CP, Lam DS . The cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn J Ophthalmol 2004; 48 (3): 236\u2013242.","journal-title":"Jpn J Ophthalmol"},{"key":"BF6702232_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/archopht.122.7.1086","volume":"122","author":"JB Jonas","year":"2004","unstructured":"Jonas JB, Degenring RF, Kreissig I . Intravitreal injection of triamcinolone for diffuse macular oedema \u2013 in reply. Arch Ophthalmol 2004; 122: 1086\u20131088.","journal-title":"Arch Ophthalmol"},{"key":"BF6702232_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/archopht.122.7.1085","volume":"122","author":"H Rodriguez-Coleman","year":"2004","unstructured":"Rodriguez-Coleman H, Yuan P, Kim H, Gravlin L, Srivastava S, Csaky KG et al. Intravitreal injection of triamcinolone for diffuse macular oedema. Arch Ophthalmol 2004; 122: 1085\u20131086.","journal-title":"Arch Ophthalmol"},{"key":"BF6702232_CR15","volume-title":"Program and Abstracts of the American Academy of Ophthalmology 2002 Meeting","author":"ML Young","year":"2002","unstructured":"Young ML, Kaiser PK, Sears JE . Acute endophthalmitis following intravitreal triamcinolone acetonide injection (abstract). In: Program and Abstracts of the American Academy of Ophthalmology 2002 Meeting. Orlando, FL, October 20\u201323, 2002."},{"key":"BF6702232_CR16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/bjo.87.8.972","volume":"87","author":"FK Sutter","year":"2003","unstructured":"Sutter FK, Gilles MC . Psuedo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003; 87: 972\u2013974.","journal-title":"Br J Ophthalmol"},{"key":"BF6702232_CR17","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","volume":"121","author":"DB Roth","year":"2003","unstructured":"Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA et al. Non- infectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 121: 1279\u20131282.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"BF6702232_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","volume":"23","author":"ML Nelson","year":"2003","unstructured":"Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 23 (5): 686\u2013691.","journal-title":"Retina"},{"key":"BF6702232_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/archopht.121.11.1663-a","volume":"121","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF . Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 2003; 121: 1663\u20131664.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"BF6702232_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ajo.2004.03.025","volume":"138","author":"AA Moshfeghi","year":"2004","unstructured":"Moshfeghi AA, Scott IU, Flynn Jr HW, Puliafito CA . Psuedohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 2004; 138 (3): 489\u2013492.","journal-title":"Am J Ophthalmol"},{"key":"BF6702232_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","volume":"136","author":"DM Moshfegi","year":"2003","unstructured":"Moshfegi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791\u2013796.","journal-title":"Am J Ophthalmol"},{"issue":"27","key":"BF6702232_CR22","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"30; 351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunnigham Jr ET, Feinsod M, Guyer DR et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 30; 351 (27): 2805\u20132816.","journal-title":"N Engl J Med"},{"issue":"6","key":"BF6702232_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ajo.2004.01.028","volume":"137","author":"SDM Chen","year":"2004","unstructured":"Chen SDM, Mohammed Q, Bowling B, Patel CK . Vitreous wick syndrome\u2014a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am J Ophthalmol 2004; 137 (6): 1159\u20131160.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"BF6702232_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ajo.2004.12.002","volume":"139","author":"MS Ibarra","year":"2005","unstructured":"Ibarra MS, Hermel M, Prenner JL, Hassan TS et al. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 2005; 139 (5): 831\u2013836.","journal-title":"Am J Ophthalmol"},{"key":"BF6702232_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/archopht.122.3.336","volume":"122","author":"MC Gillies","year":"2004","unstructured":"Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W et al. Safety of intravitreal injection of triamcinolone. Arch Ophthalmol 2004; 122: 336\u2013340.","journal-title":"Arch Ophthalmol"},{"key":"BF6702232_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1046\/j.1440-1606.1999.00238.x","volume":"27","author":"RJ Wingate","year":"1999","unstructured":"Wingate RJ, Beaumont PE . Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999; 27: 431\u2013432.","journal-title":"Aust NZ J Ophthalmol"},{"key":"BF6702232_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/bjo.87.1.24","volume":"87","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF . Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24\u201327.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6702232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:24:13Z","timestamp":1684412653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6702232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,27]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BF6702232"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6702232","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,27]]}}}